NEW YORK (GenomeWeb) – With a $600,000 grant from the Sohn Conference Foundation, Weill Cornell Medicine has launched a new project to develop liquid biopsy monitoring tests to predict the spread or the recurrence of cancer in children and adults.

The effort, called the Sohn Collaborative for Liquid Biopsy at Weill Cornell Medicine, will investigate biomarkers that predict whether cancer will spread and to which organs, with the aim of helping clinicians prevent or manage relapse at distant sites.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.